Literature DB >> 16997129

Activation of prostaglandin E receptor EP4 subtype suppresses food intake in mice.

Kousaku Ohinata1, Kentaro Suetsugu, Yoko Fujiwara, Masaaki Yoshikawa.   

Abstract

Prostaglandin (PG) E2, a bioactive lipid produced in the brains of various mammals, decreases food intake after central administration. We examined which of four distinct subtypes of PGE2 receptors (EP1-EP4) mediated the anorexigenic action of PGE2 using highly selective ligands. PGE2 at a dose of 0.1-10 nmol/mouse decreased food intake after intracerebroventricular (i.c.v.) administration in a dose-dependent manner in fasted mice. A centrally administered EP4 agonist, ONO-AE1-329 at a dose of 1-10 nmol/mouse mimicked the anorexigenic action by PGE2. The anorexigenic action of PGE2 or EP4 agonist was ameliorated by EP4 antagonist ONO-AE3-208 at a dose of 10 nmol/mouse. Thus, activation of PGE2-EP4 signaling in the central nervous system suppresses food intake. The EP4 agonist at a dose of 10 nmol/mouse delayed gastric emptying and elevated blood glucose.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16997129     DOI: 10.1016/j.prostaglandins.2006.06.008

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  17 in total

1.  Prostaglandin riddles in energy metabolism: E is for excess, D is for depletion. Focus on "Food deprivation alters thermoregulatory responses to lipopolysaccharide by enhancing cryogenic inflammatory signaling via prostaglandin D2".

Authors:  Andrej A Romanovsky; Andras Garami
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-04-21       Impact factor: 3.619

2.  Neural controls of prostaglandin 2 pyrogenic, tachycardic, and anorexic actions are anatomically distributed.

Authors:  Karolina P Skibicka; Amber L Alhadeff; Theresa M Leichner; Harvey J Grill
Journal:  Endocrinology       Date:  2011-03-29       Impact factor: 4.736

3.  PGE2 maintains the tone of the guinea pig trachea through a balance between activation of contractile EP1 receptors and relaxant EP2 receptors.

Authors:  J Säfholm; S-E Dahlén; I Delin; K Maxey; K Stark; L-O Cardell; M Adner
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

Review 4.  Stress responses: the contribution of prostaglandin E(2) and its receptors.

Authors:  Tomoyuki Furuyashiki; Shuh Narumiya
Journal:  Nat Rev Endocrinol       Date:  2010-11-30       Impact factor: 43.330

5.  Deletion of EP4 on bone marrow-derived cells enhances inflammation and angiotensin II-induced abdominal aortic aneurysm formation.

Authors:  Eva H C Tang; Eugenia Shvartz; Koichi Shimizu; Viviane Z Rocha; Chunyu Zheng; Daiju Fukuda; Guo-Ping Shi; Galina Sukhova; Peter Libby
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-18       Impact factor: 8.311

Review 6.  Neural circuitry engaged by prostaglandins during the sickness syndrome.

Authors:  Clifford B Saper; Andrej A Romanovsky; Thomas E Scammell
Journal:  Nat Neurosci       Date:  2012-07-26       Impact factor: 24.884

7.  In vitro and in vivo pharmacological role of TLQP-21, a VGF-derived peptide, in the regulation of rat gastric motor functions.

Authors:  C Severini; G La Corte; G Improta; M Broccardo; S Agostini; C Petrella; V Sibilia; F Pagani; F Guidobono; I Bulgarelli; G L Ferri; C Brancia; A M Rinaldi; A Levi; R Possenti
Journal:  Br J Pharmacol       Date:  2009-05-19       Impact factor: 8.739

8.  Thermoregulation via Temperature-Dependent PGD2 Production in Mouse Preoptic Area.

Authors:  Tongfei A Wang; Chin Fen Teo; Malin Åkerblom; Chao Chen; Marena Tynan-La Fontaine; Vanille Juliette Greiner; Aaron Diaz; Michael T McManus; Yuh Nung Jan; Lily Y Jan
Journal:  Neuron       Date:  2019-05-28       Impact factor: 17.173

9.  Proteomic profiling of the hypothalamus in a mouse model of cancer-induced anorexia-cachexia.

Authors:  R Ihnatko; C Post; A Blomqvist
Journal:  Br J Cancer       Date:  2013-09-03       Impact factor: 7.640

Review 10.  E-type prostanoid receptor 4 (EP4) in disease and therapy.

Authors:  Viktoria Konya; Gunther Marsche; Rufina Schuligoi; Akos Heinemann
Journal:  Pharmacol Ther       Date:  2013-03-21       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.